NCT02506465 - Pivotal Study to Assess the Safety and Effectiveness of the iTind Device | Biotech Hunter

Enrollment

185

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions

Benign Prostate Hyperplasia

Interventions

DEVICE

iTIND

Temporary Implantable Nitinol Device (iTIND)

PROCEDURE

Sham Arm

Foley catheter will be placed and immediately removed.

Trial Locations (13)

Manhattan Medical research, Manhattan

Weill cornell, Manhattan

Methodist Hospital, Brooklyn

Winthrop University, Garden City

St John's Episcopal, Lawrence

Integrated Medical Professionals, Long Island City

Primier Medical Center, Poughkeepsie

Chesapeake Urology Research Associates, Baltimore

Carolina Uro Research Center, Myrtle Beach

Clinical Research Center of Florida, Pompano Beach

Premier Urology Group, New York

CIUSS de l'Estrie-CHUS, Sherbrooke

Toronto, Toronto